Total Payments
$22,963
2024 Payments
$1,774
Companies
67
Transactions
1,408
Medicare Patients
13,948
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$22,165 (96.5%)
Travel$785.29 (3.4%)
Education$12.90 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,165 | 1,400 | 96.5% |
| Travel and Lodging | $785.29 | 5 | 3.4% |
| Education | $12.90 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,208 | 162 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,703 | 150 | $0 (2024) |
| PFIZER INC. | $2,254 | 168 | $0 (2024) |
| Novo Nordisk Inc | $2,009 | 112 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,153 | 88 | $0 (2024) |
| ABBVIE INC. | $1,056 | 75 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $900.01 | 9 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $892.70 | 72 | $0 (2024) |
| Astellas Pharma US Inc | $887.15 | 57 | $0 (2024) |
| Merck Sharp & Dohme LLC | $792.97 | 80 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,774 | 112 | GlaxoSmithKline, LLC. ($228.18) |
| 2023 | $2,373 | 131 | GlaxoSmithKline, LLC. ($345.31) |
| 2022 | $2,259 | 143 | GlaxoSmithKline, LLC. ($334.05) |
| 2021 | $2,706 | 180 | GlaxoSmithKline, LLC. ($392.12) |
| 2020 | $2,404 | 150 | AstraZeneca Pharmaceuticals LP ($669.60) |
| 2019 | $2,928 | 184 | GlaxoSmithKline, LLC. ($471.35) |
| 2018 | $4,547 | 245 | Actelion Pharmaceuticals US, Inc. ($900.01) |
| 2017 | $3,972 | 263 | AstraZeneca Pharmaceuticals LP ($694.16) |
All Payment Transactions
1,408 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Immunology | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Biological | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $1.09 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,776 | 7,342 | $670,698 | $370,551 |
| 2022 | 30 | 4,117 | 7,875 | $698,282 | $385,686 |
| 2021 | 27 | 4,135 | 7,929 | $712,963 | $400,732 |
| 2020 | 22 | 1,920 | 4,207 | $408,175 | $200,716 |
Total Patients
13,948
Total Services
27,353
Medicare Billing
$1.4M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 706 | 1,516 | $250,140 | $115,410 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 692 | 1,905 | $209,550 | $105,977 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 485 | 485 | $63,050 | $59,180 | 93.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 87 | 719 | $53,925 | $34,938 | 64.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 39 | 41 | $11,398 | $8,515 | 74.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 167 | 220 | $8,288 | $7,913 | 95.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 441 | 441 | $8,820 | $7,546 | 85.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 37 | 44 | $9,240 | $6,228 | 67.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 169 | 475 | $14,250 | $4,153 | 29.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 208 | 439 | $10,975 | $4,051 | 36.9% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 23 | 23 | $4,255 | $3,064 | 72.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 143 | 173 | $3,460 | $2,767 | 80.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,750 | $2,667 | 39.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $2,660 | $2,075 | 78.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 33 | 62 | $3,720 | $1,812 | 48.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 150 | 261 | $2,610 | $870.57 | 33.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 22 | $1,540 | $816.70 | 53.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 12 | 22 | $1,650 | $678.35 | 41.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 48 | 52 | $1,040 | $505.72 | 48.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 21 | 23 | $414.00 | $372.60 | 90.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 20 | $700.00 | $323.57 | 46.2% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 42 | 58 | $870.00 | $216.38 | 24.9% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 15 | $300.00 | $165.45 | 55.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 11 | 11 | $275.00 | $144.32 | 52.5% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 13 | 13 | $195.00 | $109.50 | 56.2% |
About Dr. Sunil Sharma, MD
Dr. Sunil Sharma, MD is a Family Medicine healthcare provider based in Opelika, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376604272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Sharma, MD has received a total of $22,963 in payments from pharmaceutical and medical device companies, with $1,774 received in 2024. These payments were reported across 1,408 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($22,165).
As a Medicare-enrolled provider, Sharma has provided services to 13,948 Medicare beneficiaries, totaling 27,353 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Opelika, AL
- Active Since 12/13/2006
- Last Updated 12/04/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1376604272
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,837
- FARXIGA (Drug) $1,617
- ELIQUIS (Drug) $958.94
- Ozempic (Drug) $918.82
- XARELTO (Drug) $908.87
- VRAYLAR (Drug) $859.90
- Vascepa (Drug) $777.69
- JARDIANCE (Drug) $746.30
- JANUVIA (Drug) $539.32
- ENTRESTO (Drug) $503.37
- Victoza (Drug) $469.74
- MYRBETRIQ (Drug) $457.14
- BEVESPI AEROSPHERE (Drug) $426.20
- SYMBICORT (Drug) $395.11
- LYRICA (Drug) $360.79
- CHANTIX (Drug) $294.38
- ANORO (Drug) $294.01
- Tresiba (Drug) $278.34
- FREESTYLE LIBRE 3 (Device) $267.86
- Trintellix (Drug) $258.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Opelika
Dr. Eric Hemberg, Md, MD
Family Medicine — Payments: $15,917
Family Medicine $15,917
Dr. Keith Fuller, D.o, D.O
Family Medicine — Payments: $12,787
Family Medicine $12,787
Dr. Brian Rogers, M.d, M.D
Family Medicine — Payments: $7,490
Family Medicine $7,490
Sara Norris, Crnp, CRNP
Family Medicine — Payments: $6,666
Family Medicine $6,666
Dr. John Cooper, M.d, M.D
Family Medicine — Payments: $5,864
Family Medicine $5,864
Dr. Hiren Patel, M.d, M.D
Family Medicine — Payments: $3,763
Family Medicine $3,763